Owner/Developer: B‘SYS GmbH
As a contract research organization (CRO) B‘SYS provides assistance to pharmaceutical settings in Ion Channel Discovery. The company focuses on the fast screening of new substances on ion channel drug targets. B‘SYS‘ technological innovation serves electrophysiological tools for HTS Drug Discovery needs in lead identification and candidate selection. EU-NETVAL member.
|Relevance:||Replacement - Reduction|
|Purpose:||Regulatory testing - Toxicological and safety evaluation - Method development - Validation|
|Technology/Tools:||Alternative test methods (in vitro) - Analytics|
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot respond unless you supply your email address.
What are you looking for?
Please give us your feedback so we can improve the information on the page. Thank you in advance for your help. Please add your email address if you would like a reply.Please contact us by email if you have any questions.